Ghrelin, a novel endogenous ligand for the GH secretagogue receptor, has been reported to stimulate GH secretion and food intake in both humans and other animals. Interestingly, recent data indicate that ghrelin is up- and down-regulated in anorexia nervosa (AN) and obesity, which are also known to be accompanied by increased and reduced GH levels respectively. Ageing is associated with a gradual but progressive reduction in GH secretion, and by alterations in appetite and food intake. The role of ghrelin in the decline of somatotroph function and the anorexia of ageing is unknown. To investigate the influence of age on circulating levels of ghrelin, a total of 19 young and old normal weight subjects (Y-NW, n=12; O-NW, n=7), six patients with active AN (A-AN), and seven patients with morbid obesity (OB) were studied. In addition to fasting plasma ghrelin concentrations, baseline serum TSH, IGF-I and insulin levels were measured. Mean plasma ghrelin concentrations in A-AN or OB were higher and lower respectively than those present in Y-NW. Interestingly, mean plasma ghrelin concentrations in O-NW were significantly lower than those present in Y-NW and superimposable on those of OB. The mean fasting plasma ghrelin concentrations in all groups of subjects were negatively correlated with body mass index and serum insulin levels, but not with TSH and IGF-I levels. This study provides evidence of an age-related decline of plasma ghrelin concentrations, which might explain, at least partially, the somatotroph dysregulation and the anorexia of the elderly subject.

This article has been cited by other articles:

				L. Dossus, J. D. McKay, F. Canzian, S. Wilkening, S. Rinaldi, C. Biessy, A. Olsen, A. Tjonneland, M. U. Jakobsen, K. Overvad, et al. Polymorphisms of genes coding for ghrelin and its receptor in relation to anthropometry, circulating levels of IGF-I and IGFBP-3, and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) Carcinogenesis, July 1, 2008; 29(7): 1360 - 1366. [Abstract] [Full Text] [PDF]

				M. Yukawa, D. S. Weigle, C. D. Davis, B. T. Marck, and T. Wolden-Hanson Peripheral ghrelin treatment stabilizes body weights of senescent male Brown Norway rats at baseline and after surgery Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1453 - R1460. [Abstract] [Full Text] [PDF]

				M. G.-S. Frutos, L. Cacicedo, C. Fernandez, D. Vicent, B. Velasco, H. Zapatero, and F. Sanchez-Franco Insights into a role of GH secretagogues in reversing the age-related decline in the GH/IGF-I axis Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1140 - E1152. [Abstract] [Full Text] [PDF]

				S Bertoli, P Magni, V Krogh, M Ruscica, E Dozio, G Testolin, and A Battezzati Is ghrelin a signal of decreased fat-free mass in elderly subjects? Eur. J. Endocrinol., August 1, 2006; 155(2): 321 - 330. [Abstract] [Full Text] [PDF]

				V. Di Francesco, M. Zamboni, E. Zoico, G. Mazzali, A. Dioli, F. Omizzolo, L. Bissoli, F. Fantin, P. Rizzotti, S. B Solerte, et al. Unbalanced serum leptin and ghrelin dynamics prolong postprandial satiety and inhibit hunger in healthy elderly: another reason for the "anorexia of aging" Am. J. Clinical Nutrition, May 1, 2006; 83(5): 1149 - 1152. [Abstract] [Full Text] [PDF]

				A. E. Rigamonti, S. M. Bonomo, D. Scanniffio, S. G. Cella, and E. E. Muller Orexigenic effects of a growth hormone secretagogue and nitric oxide in aged rats and dogs: correlation with the hypothalamic expression of some neuropeptidergic/receptorial effectors mediating food intake. J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2006; 61(4): 315 - 322. [Abstract] [Full Text] [PDF]

				T Akamizu, T Murayama, S Teramukai, K Miura, I Bando, T Irako, H Iwakura, H Ariyasu, H Hosoda, H Tada, et al. Plasma ghrelin levels in healthy elderly volunteers: the levels of acylated ghrelin in elderly females correlate positively with serum IGF-I levels and bowel movement frequency and negatively with systolic blood pressure J. Endocrinol., February 1, 2006; 188(2): 333 - 344. [Abstract] [Full Text] [PDF]

				M. Perez-Fontan, F. Cordido, A. Rodriguez-Carmona, J. Peteiro, R. Garcia-Naveiro, and J. Garcia-Buela Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis Nephrol. Dial. Transplant., August 1, 2004; 19(8): 2095 - 2100. [Abstract] [Full Text] [PDF]

				Y. Sun, P. Wang, H. Zheng, and R. G. Smith Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor PNAS, March 30, 2004; 101(13): 4679 - 4684. [Abstract] [Full Text] [PDF]

				A. INUI, A. ASAKAWA, C. Y. BOWERS, G. MANTOVANI, A. LAVIANO, M. M. MEGUID, and M. FUJIMIYA Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ FASEB J, March 1, 2004; 18(3): 439 - 456. [Abstract] [Full Text] [PDF]

				J. E. Morley The Top 10 Hot Topics in Aging J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2004; 59(1): M24 - 33. [Full Text] [PDF]

				Y. Sun, S. Ahmed, and R. G. Smith Deletion of Ghrelin Impairs neither Growth nor Appetite Mol. Cell. Biol., November 15, 2003; 23(22): 7973 - 7981. [Abstract] [Full Text] [PDF]

				M.-M. G. Wilson and J. E. Morley Invited Review: Aging and energy balance J Appl Physiol, October 1, 2003; 95(4): 1728 - 1736. [Abstract] [Full Text] [PDF]

				S. M. Poykko, E. Kellokoski, S. Horkko, H. Kauma, Y. A. Kesaniemi, and O. Ukkola Low Plasma Ghrelin Is Associated With Insulin Resistance, Hypertension, and the Prevalence of Type 2 Diabetes Diabetes, October 1, 2003; 52(10): 2546 - 2553. [Abstract] [Full Text] [PDF]

				C. Anderwald, G. Brabant, E. Bernroider, R. Horn, A. Brehm, W. Waldhausl, and M. Roden Insulin-Dependent Modulation of Plasma Ghrelin and Leptin Concentrations Is Less Pronounced in Type 2 Diabetic Patients Diabetes, July 1, 2003; 52(7): 1792 - 1798. [Abstract] [Full Text] [PDF]